Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. [electronic resource]
- Nature reviews. Rheumatology 11 2016
- 645-657 p. digital
Publication Type: Journal Article; Review
1759-4804
10.1038/nrrheum.2016.158 doi
Antibodies, Monoclonal, Humanized--therapeutic use Antigens, CD20--immunology B-Cell Activating Factor--immunology B-Lymphocytes--immunology Clinical Trials as Topic Cytokines--immunology Evidence-Based Medicine Humans Leukocyte Reduction Procedures--methods Lupus Erythematosus, Systemic--drug therapy T-Lymphocytes--immunology